SCHEMBL27006607

SCHEMBL27006607

O=C(Nc1ccccc1)C1(C(=O)NC2CC2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
EPHX1 P07099 1/20 0.51
RAB9A P51151 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
HPGD P15428 2/20 0.44
LMNA P02545 1/20 0.44
SPHK1 Q9NYA1 6/20 0.44
ALDH1A1 P00352 2/20 0.43
FAAH O00519 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
DDB1 Q16531 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29577773 0.94 EPHX1 (0.60) EPHX2SMN1; SMN2EPHX1RAB9AL3MBTL1
SCHEMBL29576935 0.92 EPHX1 (0.63) EPHX2SMN1; SMN2EPHX1RAB9ACYP2C9
SCHEMBL29577155 0.92 EPHX1 (0.63) EPHX2SMN1; SMN2EPHX1RAB9ACYP2C9
SCHEMBL9304492 0.86 TSHR (0.54) EPHX2SMN1; SMN2EPHX1CYP1A2CYP2C9
SCHEMBL27006605 0.83 ALDH1A1 (0.51) SMN1; SMN2RAB9AL3MBTL1LMNAALDH1A1
SCHEMBL27006611 0.80 KMT2A (0.60) EPHX2L3MBTL1TSHRLMNAALDH1A1
SCHEMBL106428 0.79 SPHK1 (0.50) EPHX2SMN1; SMN2EPHX1CYP1A2CYP2C9
SCHEMBL12469141 0.78 EPHX2 (0.42) EPHX2SMN1; SMN2EPHX1RAB9AHPGD
SCHEMBL10202156 0.78 TSHR (0.48) EPHX2SMN1; SMN2EPHX1CYP1A2CYP2C9
SCHEMBL17993520 0.78 NAPRT (0.47) EPHX2SMN1; SMN2EPHX1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016149-A1 HERBICIDAL MALONAMIDES BASF SE (DE) 2024-01-18 US claimed
EP-4251606-A1 HERBICIDAL MALONAMIDES BASF SE (DE) 2023-10-04 EP claimed
WO-2022112347-A1 HERBICIDAL MALONAMIDES BASF SE (DE) 2022-06-02 WO claimed
US-20240016149-A1 HERBICIDAL MALONAMIDES BASF SE (DE) 2024-01-18 US disclosed
EP-4251606-A1 HERBICIDAL MALONAMIDES BASF SE (DE) 2023-10-04 EP disclosed
WO-2022112347-A1 HERBICIDAL MALONAMIDES BASF SE (DE) 2022-06-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016149-A1 HERBICIDAL MALONAMIDES DDT, ACE, ME1 EPHX2 397/4885SMN1; SMN2 3789/4885EPHX1 314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.